CTKB vs HPE · rev $92.3M vs P/E 20, rev $32.19B
Cytek Biosciences Inc (CTKB) versus Hewlett Packard Enterprise Co (HPE) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Hewlett Packard Enterprise Co (HPE) is a communication equipment company listed on US.
Latest reported CTKB revenue for 2026-06-30 was $92.3M. Net income was -$31.0M. CTKB currently screens at market cap $421.8M.
Latest reported HPE revenue for 2026-07-31 was $32.19B. Net income was $2.62B. Revenue was up 61.1% from 2026-04-30 to 2026-07-31. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
CTKB currently screens at market cap $421.8M. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
Not investment advice. Open the CTKB and HPE stock pages for the full models.
Not investment advice.